Admitted local publications that cite Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study.
No admitted local citation edges point to this work yet.
Cited by — Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study | ResearchHub - ResearchHub
